Effects of Treatment Intensification on Acute Local Toxicity During Radiotherapy for Head and Neck Cancer: Prospective Observational Study Validating CTCAE, Version 3.0, Scoring System

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 2, 2008, Pages 330-337

  Palazzi, Mauro ^a   Tomatis, Stefano ^a   Orlandi, Ester ^a   Guzzo, Marco ^a   Sangalli, Claudia ^a   Potepan, Paolo ^a   Fantini, Simona ^a   Bergamini, Cristiana ^a   Gavazzi, Cecilia ^a   Licitra, Lisa ^a   Scaramellini, Gabriele ^a   Cantu', Giulio ^a   Olmi, Patrizia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Acute toxicity; CTCAE; Head and neck cancer; Radiotherapy; Scoring system

Indexed keywords

CHEMOTHERAPY; RADIOTHERAPY; TOXICITY;

ACUTE TOXICITY; MULTIVARIATE ANALYSIS; NECK CANCER; SCORING SYSTEMS;

ONCOLOGY;

ACUTE TOXICITY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; DYSPHAGIA; FEMALE; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PAIN; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DERMATITIS; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SALIVARY GLAND; SCORING SYSTEM; SEX RATIO; SKIN TOXICITY; THERAPY EFFECT; VALIDATION STUDY; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DEGLUTITION DISORDERS; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAIN; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIODERMATITIS; SEVERITY OF ILLNESS INDEX; STOMATITIS; TERMINOLOGY AS TOPIC; WEIGHT LOSS; XEROSTOMIA;

EID: 38149020031     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.06.022     Document Type: Article

References (31)

1. Bernier J., and Bentzen S.M. Radiotherapy for head and neck cancer: Latest developments and future perspectives. Curr Opin Oncol 18 (2006) 240-246
2. Chen Y., Trotti A., Coleman C.N., et al. Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation. Int J Radiat Oncol Biol Phys 64 (2006) 1442-1451
3. Trotti A., and Bentzen S.M. The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol 22 (2004) 19-22
4. Robbins K.T. Barriers to winning the battle with head-and-neck cancer. Int J Radiat Oncol Biol Phys 53 (2002) 4-5
5. Trotti A. Toxicity in head and neck cancer: A review of trends and issues. Int J Radiat Oncol Biol Phys 47 (2000) 1-12
6. Trotti A., Byhardt R., Stetz J., et al. Common toxicity criteria, version 2.0-An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. Int J Radiat Oncol Biol Phys 47 (2000) 13-47
7. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
8. Williams J., Chen Y., Rubin P., et al. The biological basis of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 182-188
9. National Cancer Institute CTEP. CTCAE v3.0. Available at: http://ctep.cancer.gov/reporting/ctc.html. Accessed January 16, 2007.
10. Pajak T.F., Trotti A., Gwede C.K., et al. The TAME risk classification system: Acute toxicity burden and IPD analysis of RTOG 90-03. [Abstract]. Int J Radiat Oncol Biol Phys 63 Suppl. (2005) S131
11. Scully C., Epstein J., and Sonis S. Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: Diagnosis and management of mucositis. Head Neck 26 (2004) 77-84
12. Trotti A., Bellm L.A., Epstein J.B., et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol 66 (2003) 253-262
13. Vera-Llonch M., Oster G., Hagiwara M., et al. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 106 (2006) 329-336
14. Bieri S., Bentzen S.M., Huguenin P., et al. Early morbidity after radiotherapy with or without chemotherapy in advanced head and neck cancer: Experience from four nonrandomized studies. Strahlenther Onkol 179 (2003) 390-395
15. Beaver M.E., Matheny K.E., Roberts D.B., et al. Predictors of weight loss during radiation therapy. Otolaryngol Head Neck Surg 125 (2001) 645-648
16. Lin A., Jabbari S., Worden F.P., et al. Metabolic abnormalities associated with weight loss during chemoirradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1413-1418
17. Rosenthal D.I., Lewin J.S., and Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 24 (2006) 2636-2643
18. Akst L.M., Chan J., Elson P., et al. Functional outcomes following chemoradiotherapy for head and neck cancer. Otolaryngol Head Neck Surg 131 (2004) 950-957
19. Newman L.A., Vieira F., Schwiezer V., et al. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 124 (1998) 589-592
20. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
21. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
22. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
23. Fu K.K., Pajak T.F., Trotti A., et al. A RTOG phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
24. Overgaard J., Hansen H.S., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial. Lancet 362 (2003) 933-940
25. Ang K.K., Harris J., Garden A.S., et al. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation Therapy Oncology Group phase II trial 99-14. J Clin Oncol 23 (2005) 3008-3015
26. de Arruda F.F., Puri D.R., Zhung J., et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 64 (2006) 363-373
27. Allen A.M., Elshaikh M., Worden F.P., et al. Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer. Head Neck 29 (2007) 137-142
28. Lau H., Brar S., Hao D., et al. Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck: Analysis of survival and toxicity. Head Neck 28 (2006) 189-196
29. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
30. Green S., and Weiss G.R. Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 10 (1992) 239-253
31. Dorr W., and Hendry J.H. Consequential late effects in normal tissues. Radiother Oncol 61 (2001) 223-231